1. Seyedian SS, Nokhostin F, Malamir MD (2019): A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 12: 113-122.
2.
Zhang YZ, Li YY (2014): Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20: 91-99.
3.
Saez A, Herrero-Fernandez B, Gomez-Bris R, et al. (2023): Pathophysiology of inflammatory bowel disease: Innate immune system. Int J Mol Sci 24: 1526.
4.
Ramos GP, Papadakis KA (2019): Mechanisms of disease: Inflammatory bowel diseases. Mayo Clin Proc 94: 155-165.
5.
Na SY, Moon W (2019): Perspectives on current and novel treatments for inflammatory bowel disease. Gut Liver 13: 604-616.
6.
Plichta DR, Graham DB, Subramanian S, Xavier RJ (2019): Therapeutic opportunities in inflammatory bowel disease: Mechanistic dissection of host-microbiome relationships. Cell 178: 1041-1056.
7.
Wang Y, Wang P, Zhang Y, et al. (2020): Decreased expression of the host long-noncoding RNA-GM facilitates viral escape by inhibiting the kinase activity TBK1 via S-glutathionylation. Immunity 53: 1168-1181.e7.
8.
Kim J, Piao HL, Kim BJ, et al. (2018): Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet 50: 1705-1715.
9.
Ma D, Cao Y, Wang Z, et al. (2019): CCAT1 lncRNA promotes inflammatory bowel disease malignancy by destroying intestinal barrier via downregulating miR-185-3p. Inflamm Bowel Dis 25: 862-874.
10.
Mirza AH, Berthelsen CH, Seemann SE, et al. (2015): Transcriptomic landscape of lncRNAs in inflammatory bowel disease. Genome Med 7: 39.
11.
Lucafò M, Pugnetti L, Bramuzzo M (2019): Long non-coding RNA GAS5 and intestinal MMP2 and MMP9 expression: A translational study in pediatric patients with IBD. Int J Mol Sci 20: 5280.
12.
Lucafò M, Di Silvestre A, Romano M, et al. (2018): Role of the long non-coding RNA growth arrest-specific 5 in glucocorticoid response in children with inflammatory bowel disease. Basic Clin Pharmacol Toxicol 122: 87-93.
13.
Curci D, Franzin M, Zudeh G, et al. (2024): Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5. Eur J Pediatr 183: 1657-1665.
14.
Polytarchou C, Oikonomopoulos A, Mahurkar S, et al. (2015): Assessment of circulating MicroRNAs for the diagnosis and disease activity evaluation in patients with ulcerative colitis by using the nanostring technology. Inflamm Bowel Dis 21: 2533-2539.
15.
Yang J, Zheng XG, Wu YL, et al. (2022): Intestinal epithelial cell-derived exosomes package microRNA-23a-3p alleviate gut damage after ischemia/reperfusion via targeting MAP4K4. Biomed Pharmacother 149: 112810.
16.
Parang B, Thompson JJ, Williams CS (2018): Blood vessel epicardial substance (BVES) in junctional signaling and cancer. Tissue Barriers 6: 1-12.
17.
Choksi YA, Reddy VK, Singh K, et al. (2018): BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11: 1363-1374.
18.
Shaker OG, Safa A, Khairy A, Abozeid NF (2023): Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease. Mol Biol Rep 50: 9029-9036.
19.
Li P, Shi DP, Jin T, et al. (2022): MTA1 aggravates experimental colitis in mice by promoting transcription factor HIF1A and up-regulating AQP4 expression. Cell Death Discov 8: 298.
20.
Sanchez Calle A, Kawamura Y, Yamamoto Y, et al. (2018): Emerging roles of long non-coding RNA in cancer. Cancer Sci 109: 2093-2100.
21.
Chi Y, Wang D, Wang J, et al. (2019): Long non-coding RNA in the pathogenesis of cancers. Cells 2019; 8: 1015.
22.
Ye Y, Shen A, Liu A (2019): Long non-coding RNA H19 and cancer: A competing endogenous RNA. Bull Cancer 106: 1152-1159.
23.
Nie J, Zhao Q (2020): Lnc-ITSN1-2, derived from RNA sequencing, correlates with increased disease risk, activity and promotes CD4(+) T cell activation, proliferation and Th1/Th17 cell differentiation by serving as a ceRNA for IL-23R via sponging miR-125a in inflammatory bowel disease. Front Immunol 11: 852.
24.
Yang F, Li XF, Cheng LN, Li XL (2019): Long non-coding RNA CRNDE promotes cell apoptosis by suppressing miR-495 in inflammatory bowel disease. Exp Cell Res 382: 111484.
25.
Zeng Z, Lan Y, Chen Y, et al. (2023): LncRNA GAS5 suppresses inflammatory responses by inhibiting HMGB1 release via miR-155-5p/SIRT1 axis in sepsis. Eur J Pharmacol 942: 175520.
26.
Patel RS, Lui A, Hudson C, et al. (2023): Small molecule targeting long noncoding RNA GAS5 administered intranasally improves neuronal insulin signaling and decreases neuroinflammation in an aged mouse model. Sci Rep 13: 317.
27.
Li J, Liu S (2020): LncRNA GAS5 suppresses inflammatory responses and apoptosis of alveolar epithelial cells by targeting miR-429/DUSP1. Exp Mol Pathol 113: 104357.
28.
Gao H, Ma H, Gao M, et al. (2021): Long non-coding RNA GAS5 aggravates myocardial depression in mice with sepsis via the microRNA-449b/HMGB1 axis and the NF-B signaling pathway. Biosci Rep 41: BSR20201738.
29.
Li L, Huang C, He Y, et al. (2018): Knockdown of long non-coding RNA GAS5 increases miR-23a by targeting ATG3 involved in autophagy and cell viability. Cell Physiol Biochem 48: 1723-1734.
30.
Gao Z, Huang D (2021): lncRNA GAS5 mediated miR 23a 3p promotes inflammation and cell apoptosis by targeting TLR4 in a cell model of sepsis. Mol Med Rep 24: 510.
31.
Liu J, Chen M, Ma L, et al. (2020): LncRNA GAS5 suppresses the proliferation and invasion of osteosarcoma cells via the miR-23a-3p/PTEN/PI3K/AKT pathway. Cell Transplant 29: 963689720953093.
32.
Zhang J, Xu M (2020): Deficiency in the anti-apoptotic protein DJ-1 promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via p53. J Biol Chem 295: 4237-4251.
33.
Osler ME, Chang MS, Bader DM (2005): Bves modulates epithelial integrity through an interaction at the tight junction. J Cell Sci 118: 4667-4678.
34.
Reddy VK, Short SP, Barrett CW, et al. (2016): BVES regulates intestinal stem cell programs and intestinal crypt viability after radiation. Stem Cells 34: 1626-1636.
35.
Wen W, Wang H, Xie S, et al. (2021): BVES-AS1 inhibits the malignant behaviors of colon adenocarcinoma cells via regulating BVES. Cell Biol Int 45: 1945-1956.
36.
Mazar J, Rosado A, Shelley J, et al. (2017): The long non-coding RNA GAS5 differentially regulates cell cycle arrest and apoptosis through activation of BRCA1 and p53 in human neuroblastoma. Oncotarget 8: 6589-6607.